292 related articles for article (PubMed ID: 22028658)
1. Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells.
Imadome K; Yajima M; Arai A; Nakazawa A; Kawano F; Ichikawa S; Shimizu N; Yamamoto N; Morio T; Ohga S; Nakamura H; Ito M; Miura O; Komano J; Fujiwara S
PLoS Pathog; 2011 Oct; 7(10):e1002326. PubMed ID: 22028658
[TBL] [Abstract][Full Text] [Related]
2. A novel mouse xenotransplantation model of EBV-T/NK-LPD and the application of the mouse model.
Imadome K
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(6):433-41. PubMed ID: 24390103
[TBL] [Abstract][Full Text] [Related]
3. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.
Kasahara Y; Yachie A; Takei K; Kanegane C; Okada K; Ohta K; Seki H; Igarashi N; Maruhashi K; Katayama K; Katoh E; Terao G; Sakiyama Y; Koizumi S
Blood; 2001 Sep; 98(6):1882-8. PubMed ID: 11535525
[TBL] [Abstract][Full Text] [Related]
4. A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice.
Sato K; Misawa N; Nie C; Satou Y; Iwakiri D; Matsuoka M; Takahashi R; Kuzushima K; Ito M; Takada K; Koyanagi Y
Blood; 2011 May; 117(21):5663-73. PubMed ID: 21467545
[TBL] [Abstract][Full Text] [Related]
5. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.
Kasahara Y; Yachie A
Crit Rev Oncol Hematol; 2002 Dec; 44(3):283-94. PubMed ID: 12467968
[TBL] [Abstract][Full Text] [Related]
6. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
Front Pediatr; 2019; 7():183. PubMed ID: 31231620
[TBL] [Abstract][Full Text] [Related]
7. Immunologic difference between hypersensitivity to mosquito bite and hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection.
Lee WI; Lin JJ; Hsieh MY; Lin SJ; Jaing TH; Chen SH; Hung IJ; Yang CP; Chen CJ; Huang YC; Li SP; Huang JL
PLoS One; 2013; 8(10):e76711. PubMed ID: 24204658
[TBL] [Abstract][Full Text] [Related]
8. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes.
El-Mallawany NK; Curry CV; Allen CE
Br J Haematol; 2022 Jan; 196(1):31-44. PubMed ID: 34169507
[TBL] [Abstract][Full Text] [Related]
9. Regulation of human cell engraftment and development of EBV-related lymphoproliferative disorders in Hu-PBL-scid mice.
Wagar EJ; Cromwell MA; Shultz LD; Woda BA; Sullivan JL; Hesselton RM; Greiner DL
J Immunol; 2000 Jul; 165(1):518-27. PubMed ID: 10861091
[TBL] [Abstract][Full Text] [Related]
10. Anti-tumor effects of suberoylanilide hydroxamic acid on Epstein-Barr virus-associated T cell and natural killer cell lymphoma.
Siddiquey MN; Nakagawa H; Iwata S; Kanazawa T; Suzuki M; Imadome K; Fujiwara S; Goshima F; Murata T; Kimura H
Cancer Sci; 2014 Jun; 105(6):713-22. PubMed ID: 24712440
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis.
Toga A; Wada T; Sakakibara Y; Mase S; Araki R; Tone Y; Toma T; Kurokawa T; Yanagisawa R; Tamura K; Nishida N; Taneichi H; Kanegane H; Yachie A
J Infect Dis; 2010 Jun; 201(12):1923-32. PubMed ID: 20443735
[TBL] [Abstract][Full Text] [Related]
13. Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
Chen R; Lin Q; Zhu Y; Shen Y; Xu Q; Tang H; Cui N; Jiang L; Dai X; Chen W; Li X
Orphanet J Rare Dis; 2023 Sep; 18(1):297. PubMed ID: 37736751
[TBL] [Abstract][Full Text] [Related]
14. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells.
Westhoff Smith D; Chakravorty A; Hayes M; Hammerschmidt W; Sugden B
mBio; 2021 Dec; 12(6):e0224321. PubMed ID: 34781735
[TBL] [Abstract][Full Text] [Related]
15. Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis.
Suzuki T; Sato Y; Okuno Y; Torii Y; Fukuda Y; Haruta K; Yamaguchi M; Kawamura Y; Hama A; Narita A; Muramatsu H; Yoshikawa T; Takahashi Y; Kimura H; Ito Y; Kawada JI
J Clin Immunol; 2024 Apr; 44(4):103. PubMed ID: 38642164
[TBL] [Abstract][Full Text] [Related]
16. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.
Ohga S; Nomura A; Takada H; Tanaka T; Furuno K; Takahata Y; Kinukawa N; Fukushima N; Imai S; Hara T
J Med Virol; 2004 Nov; 74(3):449-58. PubMed ID: 15368517
[TBL] [Abstract][Full Text] [Related]
17. [Significance of detecting the EBV-DNA level in peripheral blood mononuclear cells and the EBV-infected cell type in patients with chronic active EBV infection].
Xing Y; Song HM; Wu XY; Wang W; Wei M
Zhonghua Er Ke Za Zhi; 2011 Jul; 49(7):495-500. PubMed ID: 22088177
[TBL] [Abstract][Full Text] [Related]
18. Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection.
Tsuge I; Morishima T; Kimura H; Kuzushima K; Matsuoka H
J Med Virol; 2001 Jun; 64(2):141-8. PubMed ID: 11360246
[TBL] [Abstract][Full Text] [Related]
19. [Chronic active Epstein-Barr virus infection].
Kimura H
Uirusu; 2011 Dec; 61(2):163-73. PubMed ID: 22916563
[TBL] [Abstract][Full Text] [Related]
20. Inherited Genetic Susceptibility to Nonimmunosuppressed Epstein-Barr Virus-associated T/NK-cell Lymphoproliferative Diseases in Chinese Patients.
Guan YQ; Shen KF; Yang L; Cai HD; Zhang ML; Wang JC; Long XL; Xiong J; Gu J; Zhang PL; Xiao M; Zhang W; Zhou JF
Curr Med Sci; 2021 Jun; 41(3):482-490. PubMed ID: 34170459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]